Novo Nordisk's CagriSema combines semaglutide, the active ingredient in Ozempic and Wegovy, with an amylin and calcitonin receptor agonist.
CagriSema
Creator
Creator

Created
Created
2024 Nov 10 11:53Editor
Editor

Edited
Edited
2024 Nov 10 11:54Refs
Refs